Sistema complesso per test viremie e screening batteriologico
Titre original de l'avis
Italy – Reagents and contrast media – FORNITURA DI UN SISTEMA COMPLESSO PER TEST IN AUTOMAZIONE PER LE VIREMIE PRINCIPALI (HIV-HBV-HCV-CMV) E SCREENING BATTERIOLOGICO PER MRSA E GBS IN BIOLOGIA MOLECOLARE QUANTITATIVA E QUALITATIVA NECESS
Score d'opportunité
Pourquoi ce score ?
Opportunité
65 / 100
Complexité
50 / 100
Facteurs de risque
No procurement documents were analyzed; essential details (technical specs, contract terms) are unknown.
Moderate submission timeline (approx. 5 weeks from publication).
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Aperçu
Moderate opportunityFaits clés
- EUR 784.8k estimated value
- Supplies contract
- 1 lot
- Duration 1095 DAY
- Supply automated system for viremia tests (HIV, HBV, HCV, CMV) and bacteriological screening (MRSA, GBS) using quantitative and qualitative molecular biology.
- System to be delivered to Azienda Ospedaliero Universitaria di Ferrara.
Afficher le résumé complet
Open tender for the supply of an automated system for viremia tests (HIV, HBV, HCV, CMV) and bacteriological screening (MRSA, GBS) for the Microbiology Unit of Azienda Ospedaliero Universitaria di Ferrara. The buyer is Azienda USL di Bologna. Single lot, estimated value €784,790. Submission deadline 16 July 2026. Awarded on most economically advantageous basis (quality). Only notice data available; procurement documents not analyzed.
Risques
No procurement documents were analyzed; essential details (technical specs, contract terms) are unknown.
Moderate submission timeline (approx. 5 weeks from publication).
L'analyse peut être incomplète
Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.
Exigences clés
Technical
- Automated system for molecular biology testing.
- System must handle viremia tests (HIV, HBV, HCV, CMV).
- System must handle bacteriological screening (MRSA, GBS).
Les exigences peuvent être incomplètes.
Critères d'attribution
Lot 1
Acheteur
Localisation
Bologna, ITA
Profil acheteur
Identifiant
02406911202
Activité
Health
Lots (1)
LOT-0001
Sistema complesso per test viremie e screening batteriologico
Supply of an automated system for quantitative and qualitative molecular biology testing for HIV, HBV, HCV, CMV viremias and bacteriological screening for MRSA and GBS.
EUR 784.8k
Valeur estimée
Localisation
Durée
Catégorie
Critères d'attribution
Date limite
Détails des critères
Offerta economicamente più vantaggiosa
Note sur la valeur
Afficher les données TED originales
Description TED originale
Sistema complesso per test viremie e screening batteriologico
Détails de la procédure
- Date de publication
- 07 Jun 2026
- Langues
- Italian
Métadonnées de référence
- Base juridique
- 32014L0024
Identifiants de référence
- ID de l'appel d'offres
- 390496-2026
Documents (2)
Appels d'offres similaires
Germany – Pharmaceutical products – Kontrastmittel - Wirkstoffübergreifendes Open-House-Verfahren für die KV-Region Westfalen-Lippe
Germany – Pharmaceutical products – Kontrastmittel - Wirkstoffübergreifendes Open-House-Verfahren für die KV-Region Schleswig-Holstein
Germany – Pharmaceutical products – Kontrastmittel - Wirkstoffübergreifendes Open-House-Verfahren für die KV-Region Rheinland-Pfalz/Saarland
Lithuania – Reagents and contrast media – Reagentų ir pagalbinių priemonių laboratorinių tyrimų atlikimui užsakymai per CPO LT elektroninį katalogą
Lithuania – Reagents and contrast media – Laboratorinių reagentų pirkimas
Lithuania – Reagents and contrast media – Laboratoriniai reagentai (organiniai ir (ar) neorganiniai) ir (ar) laboratoriniai prietaisai, ir (ar) laboratorijoje naudojamos priemonės
Score d'opportunité
Pourquoi ce score ?
Opportunité
65 / 100
Complexité
50 / 100
Facteurs de risque
No procurement documents were analyzed; essential details (technical specs, contract terms) are unknown.
Moderate submission timeline (approx. 5 weeks from publication).
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications